Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 11.33
+0.07 (0.62%)
Feb 4, 2026, 3:04 PM CST
SHE:301060 Revenue
Shanghai Labway Clinical Laboratory had revenue of 342.71M CNY in the quarter ending September 30, 2025, a decrease of -20.63%. This brings the company's revenue in the last twelve months to 1.52B, down -11.61% year-over-year. In the year 2024, Shanghai Labway Clinical Laboratory had annual revenue of 1.74B with 4.05% growth.
Revenue (ttm)
1.52B
Revenue Growth
-11.61%
P/S Ratio
2.94
Revenue / Employee
1.12M
Employees
1,365
Market Cap
4.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.74B | 67.81M | 4.05% |
| Dec 31, 2023 | 1.67B | -2.52B | -60.13% |
| Jan 1, 2023 | 4.20B | 2.42B | 136.14% |
| Jan 1, 2022 | 1.78B | 540.14M | 43.62% |
| Dec 31, 2020 | 1.24B | 84.69M | 7.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 7.40B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Medicalsystem Biotechnology | 1.47B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |
| Berry Genomics Co.,Ltd | 941.16M |
| SMO ClinPlus CO.,LTD. | 819.09M |